Typicality: | 0.655 |
Saliency: | 0.601 |
after passing the neurological screening | 7 | temporal |
within each village | 3 | location |
after an informed consent | 3 | manner |
subject → be included in → the study | 202 |
subject → be included in → this study | 75 |
subject → be included in → study | 13 |
subject → be included in → our study | 5 |
subject → be included into → the study | 4 |
subject → be considered for → the study | 4 |
negative | neutral | positive |
0.132 | 0.778 | 0.090 |
Raw frequency | 303 |
Normalized frequency | 0.601 |
Modifier score | 0.959 |
Perplexity | 79.071 |